MENU
+Compare
CRVO
Stock ticker: NASDAQ
AS OF
Apr 24, 12:29 PM (EDT)
Price
$8.82
Change
-$0.20 (-2.22%)
Capitalization
76.58M

CRVO CervoMed Forecast, Technical & Fundamental Analysis

CervoMed Inc is a clinical stage biotechnology company... Show more

Industry: #Biotechnology
CRVO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for CRVO with price predictions
Apr 23, 2025

CRVO's RSI Oscillator leaves overbought zone

The 10-day RSI Indicator for CRVO moved out of overbought territory on April 04, 2025. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 18 instances where the indicator moved out of the overbought zone. In of the 18 cases the stock moved lower in the days that followed. This puts the odds of a move down at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for CRVO turned negative on April 07, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 57 similar instances when the indicator turned negative. In of the 57 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CRVO declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

CRVO broke above its upper Bollinger Band on March 21, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 74 cases where CRVO's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on April 23, 2025. You may want to consider a long position or call options on CRVO as a result. In of 102 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where CRVO advanced for three days, in of 232 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CRVO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.954) is normal, around the industry mean (14.056). P/E Ratio (4.727) is within average values for comparable stocks, (63.446). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.788). Dividend Yield (0.000) settles around the average of (0.025) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (252.992).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CRVO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
CRVO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

CRVO is expected to report earnings to rise 276.62% to -290 cents per share on August 21

CervoMed CRVO Stock Earnings Reports
Q2'23
Est.
$-2.90
Q4'24
Missed
by $0.40
Q1'23
Missed
by $0.10
Q4'22
Beat
by $0.22
Q3'22
Est.
$-2.06
The last earnings report on March 17 showed earnings per share of -76 cents, missing the estimate of -37 cents. With 55.62K shares outstanding, the current market capitalization sits at 76.58M.
A.I. Advisor
published General Information

General Information

a developer of pharmaceutical products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
20 Park Plaza
Phone
+1 617 744-4400
Employees
8
Web
https://www.cervomed.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MGRM2.720.09
+3.42%
Monogram Orthopaedics
PPERY11.480.25
+2.23%
PT Bank Mandiri Persero TBK
WASH27.530.53
+1.96%
Washington Trust Bancorp
KGSPY82.581.02
+1.25%
Kingspan Group plc.
BLTE59.110.73
+1.25%
Belite Bio

CRVO and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, CRVO has been loosely correlated with TCRX. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if CRVO jumps, then TCRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRVO
1D Price
Change %
CRVO100%
+2.84%
TCRX - CRVO
34%
Loosely correlated
+4.46%
LVTX - CRVO
28%
Poorly correlated
-2.90%
VKTX - CRVO
27%
Poorly correlated
+1.22%
NKTR - CRVO
27%
Poorly correlated
+3.28%
AVXL - CRVO
27%
Poorly correlated
+0.87%
More